Cue Biopharma, Inc. (CUE)

Cue Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.7	22.46	48.51	51.61	64.37	74.87
Short-Term Investments	8.72	0.93	0.29	24.68	-	10
Cash & Short-Term Investments	20.42	23.39	48.8	76.29	64.37	84.87
Cash Growth	-37.02%	-52.08%	-36.03%	18.52%	-24.15%	42.85%
Receivables	2.29	0.95	1.7	0.06	3.14	1.42
Prepaid Expenses	3.11	0.81	0.96	0.84	0.87	1.24
Other Current Assets	-	-	-	-	0.08	-
Total Current Assets	25.82	25.14	51.45	77.19	68.47	87.53
Property, Plant & Equipment	4.91	4.84	7.12	10.7	11.92	8.88
Other Long-Term Assets	0.92	2.21	2.96	3.39	3.01	3.12
Total Assets	31.64	32.19	61.53	91.28	83.4	99.53
Accounts Payable	2.35	2.82	3.5	2.73	2.59	2.07
Accrued Expenses	1.87	2.91	4.14	3.55	4.62	2.79
Current Portion of Long-Term Debt	1.46	4.33	3.96	1.96	-	-
Current Portion of Leases	2.03	3.54	3.37	3.3	4.93	4.78
Current Unearned Revenue	7.82	0.09	2.11	-	0.65	6.68
Other Current Liabilities	-	-	-	-	0	-
Total Current Liabilities	15.52	13.69	17.08	11.55	12.79	16.32
Long-Term Debt	-	-	4.2	8.04	-	-
Long-Term Leases	2.68	1	3.16	6.02	5.12	2.37
Long-Term Unearned Revenue	-	-	-	-	-	1.94
Other Long-Term Liabilities	0.19	-	-	-	-	-
Total Liabilities	18.4	14.69	24.45	25.6	17.91	20.62
Common Stock	0.08	0.06	0.05	0.04	0.03	0.03
Additional Paid-In Capital	383.22	359.3	338.23	316.19	262.91	232.16
Retained Earnings	-370.05	-341.86	-301.19	-250.46	-197.45	-153.29
Comprehensive Income & Other	0	-	-	-0.1	-	0.01
Shareholders' Equity	13.25	17.5	37.09	65.68	65.49	78.91
Total Liabilities & Equity	31.64	32.19	61.53	91.28	83.4	99.53
Total Debt	6.17	8.88	14.7	19.32	10.05	7.15
Net Cash (Debt)	14.25	14.51	34.11	56.97	54.32	77.72
Net Cash Growth	-37.81%	-57.45%	-40.14%	4.89%	-30.11%	44.97%
Net Cash Per Share	0.17	0.26	0.75	1.60	1.74	2.71
Filing Date Shares Outstanding	78.74	61.82	48.64	43.17	33.01	30.46
Total Common Shares Outstanding	77.78	61.82	47.22	43.04	32.2	30.35
Working Capital	10.3	11.45	34.37	65.64	55.68	71.21
Book Value Per Share	0.17	0.28	0.79	1.53	2.03	2.60
Tangible Book Value	13.25	17.5	37.09	65.68	65.49	78.91
Tangible Book Value Per Share	0.17	0.28	0.79	1.53	2.03	2.60
Machinery	3.79	4.03	4.29	5.62	5.55	4.51
Construction In Progress	-	-	-	-	-	0.41
Leasehold Improvements	0.12	0.12	0.12	0.12	0.01	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q